These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33619776)

  • 21. Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE Study.
    Paul C; Leonardi C; Menter A; Reich K; Gold LS; Warren RB; Møller A; Lebwohl M
    Am J Clin Dermatol; 2017 Jun; 18(3):405-411. PubMed ID: 28236223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A cost-effectiveness analysis of calcipotriol plus betamethasone dipropionate aerosol foam versus gel for the topical treatment of plaque psoriasis.
    Foley P; Garrett S; Ryttig L
    Curr Med Res Opin; 2018 Jul; 34(7):1277-1283. PubMed ID: 29336190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris--A randomized phase II study.
    Koo J; Tyring S; Werschler WP; Bruce S; Olesen M; Villumsen J; Bagel J
    J Dermatolog Treat; 2016; 27(2):120-7. PubMed ID: 26444907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Cost-utility Analysis of Calcipotriol/Betamethasone Dipropionate Aerosol Foam versus Ointment for the Topical Treatment of Psoriasis Vulgaris in Sweden.
    Duvetorp A; Levin LÅ; Engerstedt Mattsson E; Ryttig L
    Acta Derm Venereol; 2019 Apr; 99(4):393-399. PubMed ID: 30628631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the foam formulation in improving psoriasis treatment acceptability: a real-life experience and a literature review.
    Martella A; Gasparini S; Papa S; Giovene GL
    Eur Rev Med Pharmacol Sci; 2023 Nov; 27(21):10697-10704. PubMed ID: 37975395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of an innovative aerosol foam formulation of fixed combination calcipotriol plus betamethasone dipropionate in patients with psoriasis vulgaris.
    Queille-Roussel C; Olesen M; Villumsen J; Lacour JP
    Clin Drug Investig; 2015 Apr; 35(4):239-45. PubMed ID: 25708531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of fixed-dose combination calcipotriol/betamethasone dipropionate foam for the treatment of psoriasis.
    Stein Gold L; Paul C; Romiti R
    J Eur Acad Dermatol Venereol; 2021 Feb; 35 Suppl 1():10-19. PubMed ID: 33619777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam Compared with Betamethasone 17-Valerate-Medicated Plaster for the Treatment of Psoriasis.
    Queille-Roussel C; Rosen M; Clonier F; Nørremark K; Lacour JP
    Clin Drug Investig; 2017 Apr; 37(4):355-361. PubMed ID: 27995521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-Term Proactive Treatment of Plaque Psoriasis with Calcipotriene/Betamethasone Dipropionate Foam Prolongs Remission and Reduces Relapses Irrespective of Patient Baseline Characteristics.
    Lebwohl MG; Papp KA; Mørch MH; Bernasconi MYJ; Warren RB
    Dermatol Ther (Heidelb); 2021 Oct; 11(5):1657-1665. PubMed ID: 34339017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matching-Adjusted Indirect Comparison of Long-Term Efficacy and Safety Outcomes for Calcipotriol Plus Betamethasone Dipropionate Foam Versus Halobetasol Proprionate Plus Tazarotene Lotion in the Treatment of Plaque Psoriasis.
    Adam DN; Jablonski Bernasconi MY; Thoning H; Wu JJ
    Dermatol Ther (Heidelb); 2022 Nov; 12(11):2589-2600. PubMed ID: 36223060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early efficacy and safety data with fixed-dose combination calcipotriol/betamethasone dipropionate foam attributed to mechanism of absorption and steroid potency.
    Tada Y; Iversen L; Koo J
    J Eur Acad Dermatol Venereol; 2021 Feb; 35 Suppl 1(Suppl 1):5-9. PubMed ID: 33619779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psoriasis and skin pain: real-life effectiveness of calcipotriol plus betamethasone dipropionate in aerosol foam formulation.
    Gallo L; Megna M; Cirillo T; Caterino P; Lodi G; Mozzillo R; Dente V; Balato A
    J Eur Acad Dermatol Venereol; 2019 Jul; 33(7):1312-1315. PubMed ID: 30767288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proactive Topical Maintenance Treatment of Psoriasis: Subanalysis of Canadian Patients in the Phase III PSO-LONG Trial.
    Hong HC; Adam DN; Rivers JK; Wiseman MC; Thoning H; McCracken CB
    J Cutan Med Surg; 2023; 27(1):63-64. PubMed ID: 36437761
    [No Abstract]   [Full Text] [Related]  

  • 34. Calcipotriol plus betamethasone dipropionate aerosol foam provides superior efficacy vs. gel in patients with psoriasis vulgaris: randomized, controlled PSO-ABLE study.
    Paul C; Stein Gold L; Cambazard F; Kalb RE; Lowson D; Bang B; Griffiths CE
    J Eur Acad Dermatol Venereol; 2017 Jan; 31(1):119-126. PubMed ID: 27531752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patients with psoriasis have different preferences for topical therapy, highlighting the importance of individualized treatment approaches: randomized phase IIIb PSO-INSIGHTFUL study.
    Hong CH; Papp KA; Lophaven KW; Skallerup P; Philipp S
    J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1876-1883. PubMed ID: 28796913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcipotriol/Betamethasone Dipropionate Cutaneous Foam Treatment for Psoriasis in Patients With BSA 5-15% and PGA ≥ 3: Post-Hoc Analysis From Three Randomized Controlled Trials.
    Iversen L; Kurvits M; Snel-Prentø AM; Menter A
    Dermatol Ther (Heidelb); 2020 Oct; 10(5):1111-1120. PubMed ID: 32785881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel, fixed-dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30
    Pinter A; Gold LS; Reich A; Green LJ; Praestegaard M; Selmer J; Armstrong AW; Danø A; Dhawan S; Galván J; Stallknecht SE; Trebbien P; Augustin M
    J Eur Acad Dermatol Venereol; 2023 Jan; 37 Suppl 1():14-19. PubMed ID: 36546465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient-Reported Satisfaction With the Fixed Combination Calcipotriene/Betamethasone Dipropionate Foam for Plaque Psoriasis.
    Gorelick J; Cantrell W; Kucera K; Veverka KA; Gooding K
    J Drugs Dermatol; 2018 Aug; 17(8):880-884. PubMed ID: 30124727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment Pathway.
    Maul JT; Anzengruber F; Conrad C; Cozzio A; Häusermann P; Jalili A; Kolios AGA; Laffitte E; Lapointe AK; Mainetti C; Schlapbach C; Trüeb R; Yawalkar N; Dippel M; Navarini AA
    Dermatology; 2021; 237(2):166-178. PubMed ID: 33406520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real-life effectiveness of once-daily calcipotriol and betamethasone dipropionate gel vs. ointment formulations in psoriasis vulgaris: final analysis of the 52-week PRO-long study.
    Lambert J; Hol CW; Vink J
    J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2349-55. PubMed ID: 26337069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.